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Objectives: Total hip arthroplasty (THA) is highly successful but national registries indicate
that average age has lowered and that younger patients are at higher risk of revision. Long-
term follow-up of THA was historically recommended to identify aseptically failing THA,
minimising the risks associated with extensive changes, but follow-up services are now in
decline. A systematic review was conducted to search for evidence of the clinical or cost-
effectiveness of hip arthroplasty surveillance.
Methods: The study was registered with PROSPERO International Prospective Register of
Systematic Reviews and conducted according to PRISMA guidelines; databases included
MEDLINE and Embase, and all studies were quality assessed. Original studies (2005 to
2017) reporting follow-up of adults with THA in situ >5 years were included. Researchers
extracted quantitative and qualitative data from each study.
Results: For eligibility, 4,137 studies were screened: 114 studies were included in the ﬁnal
analysis, representing 22 countries worldwide. Data extracted included study endpoint,
patient detail, loss to follow-up, revisions, scores and radiographic analysis. Six themes
were derived from inductive content analysis of text: support for long-term follow-up,
subgroups requiring follow-up, effect of materials/techniques on THA survival, effect of
design, indicators for revision, review process. Main ﬁndings—follow-up was speciﬁcally
recommended to monitor change (eg asymptomatic loosening), when outcomes of joint
construct are unknown, and for speciﬁc patient subgroups. Outcome scores alone are not
enough, and radiographic review should be included.
Conclusion: There were no studies directly evaluating the clinical effectiveness of the long-
term follow-up of THA but expert opinions from a range of international authors advocated
its use for deﬁned subgroups to provide patient-centred care. In the absence of higher level
evidence, these opinions, in conjunction with emerging outputs from the national joint
registries, should be used to inform services for long-term follow-up of THA.
Keywords: hip joint, replacement, surveillance, revision, long-term, continuing
Introduction
For many people, total hip arthroplasty (THA) is successful for treating a painful,
arthritic hip but national registries indicate that 10% of implants will subsequently
require revision, which increases to 30% for those under 50 years old at primary
surgery.1 Up to ﬁve years postoperatively, revision is predominantly undertaken for
dislocation, infection or prosthetic failure,2–4 all of which present with pain. In the
longer term, there is an increase in revision for aseptic loosening which can be
asymptomatic and thus, surveillance offeres identiﬁcation of a potential problem for
these patients. This was predominantly attributed to osteolysis generated by the
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wear debris from the widespread use of polyethylene5 but
with the change to cross-linked polyethylene, future pat-
terns of presentation may differ.
Although there is mandatory surveillance of metal-on-
metal hip arthroplasty in the UK,6 there is no mandatory
requirement for follow-up of other types of THA, and con-
cern about follow-up is widespread as arthroplasty surveil-
lance has been reduced.7–9 Some suggest it can be conducted
by general practitioners, others maintain that it should be the
orthopedic team10,11 and still others are undecided about such
services. In view of economic constraints on health services,
plus concerns about medicalization and overdiagnosis,12
long-term follow-up of any patient group must be justiﬁed
by evidence that it offers patient-centred clinical effective-
ness and cost-efﬁciency. We conducted a systematic review
of the literature to search for evidence of the clinical or cost-
effectiveness of hip arthroplasty surveillance services.
Methods
The systematic review was registered with PROSPERO,
International Prospective Register of Systematic Reviews
(https://www.crd.york.ac.uk/prospero/display_record.php?
RecordID=20517); methods were adapted from the Cochrane
Handbook13 and it was conducted according to PRISMA
guidelines,14 although not limited to randomized trials.
Inclusion and exclusion criteria
The selected population were adults with THA in situ for
longer than ﬁve years. Studies were included if they reported
any form of follow-up or surveillance or review of people
with THA, whether face-to-face or by questionnaire or by
virtual methods. Studies were excluded if reporting the
development of an outcomes tool or a surgical, radiographic
or chemical intervention, or were reporting secondary data
analysis. Evaluations of interventions in randomized con-
trolled trials were considered as cohort studies.
Literature search
We searched: MEDLINE, Embase and PsycINFO on Ovid,
CINAHL on EBSCOhost, the Cochrane Library and abstracts
of scientiﬁc meetings. Searches were limited by date (January
2005 to May 2017) and to English language. All types of
original research study were considered, including prospective
or retrospective longitudinal studies, cross-sectional studies
and randomized trials. Where a report existed of an earlier
study, the most recent published paper was retrieved. The
search strategy was developed for MEDLINE and terms
were adapted for use in other databases (Table 1).
Study selection
Titles and abstracts were screened for eligibility by two
reviewers before proceeding to the full text: inconsisten-
cies between reviewers were resolved by discussion based
on full text articles.
Data extraction
The records of all saved searches were downloaded into
Refworks© (ProQuest L.L.C.); then transferred to a
Microsoft Excel spreadsheet for cataloging decisions
on inclusion and exclusion. A second spreadsheet was
developed for data extraction which included: study
details and period, setting and country, assessment of
study endpoint, method of statistical analysis, number
and age of patients, loss to follow-up, number of revi-
sions, outcome scores and radiographic analysis, reports
of asymptomatic loosening of THA and any report of
costs or cost-effectiveness.
Following the registration in PROSPERO, a second-
ary method was employed to capture text and opinion
relating to the research question as early stages of our
review suggested a lack of studies that directly evalu-
ated follow-up services. The Joanna Briggs Institute
propose that inclusion of text, to which qualitative
review techniques are subsequently applied, provides
the opportunity to describe the insights and opinions of
authors to inform the quantitative evidence.15 A sum-
mary sentence or paragraph reporting the authors’ inter-
pretation of the ﬁndings of each study was extracted for
qualitative analysis.
A check between researchers for consistency and quality
of the extracted data was conducted after completion of the
initial 10 studies, and a further check was completed on a
random sample of 20 papers at the end of data extraction.
Table 1 Search strategy
Steps Terms
1 Hip AND replace* {No Related Terms}
2 Limit 1 to (English language and humans and year=“2005
-Current”)
3 Limit 2 to “all adult (19 plus years)”
4 (surveillance or observ* or “follow-up”).af.
5 3 and 4
6 Hip AND arthroplasty {No Related Terms}
7 Limit 6 to (English language and humans and year=“2005
-Current”)
8 Limit 7 to “all adult (19 plus years)”
9 4 and 8
Smith et al Dovepress
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Methodological quality
All the included studies were assessed for quality and
rigour against the methodological index for nonrando-
mized studies (MINORS)16 and a global score was
assigned to each. The MINORS score is a summation of
individual item scores (zero to two for each item), with
maximum of 24 for comparative studies and 16 for non-
comparative studies (Table 2).
Data analysis
Descriptive statistics were used to present quantitative
data and a method of hybrid content analysis was used
for the qualitative data.17 Primary outcome measures
were the number of joints that survived, number that
failed and number revised (or planned for revision) as
a proportion of the number and type of hip replace-
ments included in each study, plus any data on costs or
cost-effectiveness. Secondary outcomes were the type
of patient reported outcome scores and health-related
quality of life incorporated in each study.
The qualitative analysis was completed in two
phases: the ﬁrst was to apply inductive content analysis
to the data extracted from each study to inform a the-
matic framework that summarised the text on clinical
and cost-effectiveness (primary author). The second
phase was a deductive analysis, guided by the frame-
work, to verify the inductive analysis and to further
synthesize the data relating to the research question.
This second phase was conducted by two co-authors
and was an iterative process, during which the frame-
work was reviewed and amended to provide a ﬁnal
analysis agreed by all. The results were reported with
the quantitative data and a MINORS score for each
study, to allow readers to assess the textual evidence
as unequivocal, credible or unsupported.15
Results
Studies included
The review process identiﬁed 4,943 articles (4,137 after
removal of duplicates) which were screened for eligibility.
Many records were excluded because they were not THA or
presented short-term follow-up, leaving 159 potentially eligi-
ble full-text articles. A further 45 were subsequently excluded
after full-text review for reasons listed in Figure 1, leaving 114
studies for inclusion in the ﬁnal analysis. The dates of primary
surgery ranged from 1965 to 2011 and there were 22 countries
of origin. Five studies utilized a case–control method, 96 were
case series, 10 were randomized controlled trials (RCT) and
three were cohort studies. An overview of study characteristics
is shown in Table 3 and details from each study are presented
in Supplementary materials.
Quality assessment
All studies included clear aims and outcomes, and the
design was prospective in 50%. The MINORS scores
can be seen in Figures 2 and 3. Three of the studies
reported a sample size calculation and statistical ana-
lysis was most commonly a prosthesis survival
statistic.
Clinical effectiveness
The data showed a wide range in age and number of
patients (Table 4). None of the studies speciﬁcally eval-
uated the clinical effectiveness of follow-up in terms of
beneﬁt to the patients or the providers through diagnosis
of asymptomatic changes although data relevant to the
clinical effectiveness of follow-up included the reporting
of radiographic review of THA (86% of studies), reports
of asymptomatic loosening (36% of studies) and the
number of revision hip arthroplasties (Table 4). The use
of patient-reported outcome measures, which are
designed to capture changes in function and symptoms
as perceived by the patient, increased over time. The
most frequently used outcome measure was the Harris
Hip Score, which became widely adopted by English-
speaking orthopedic communities as a surgeon-completed
score following initial publication in 1969.18 The geogra-
phical and time-related use of outcome scores can be
seen in Table 5.
Table 2 Methodological items for nonrandomized studies
(MINORS)
1 A clearly stated aim
2 Inclusion of consecutive patients
3 Prospective collection of data
4 Endpoints appropriate to the aim of the study
5 Unbiased assessment of the study endpoint
6 Follow-up period appropriate to the aim of the study
7 Loss to follow-up less than 5%
8 Prospective calculation of the study size
Additional criteria in the case of comparative study
9 An adequate control group
10 Contemporary groups
11 Baseline equivalence of groups
12 Adequate statistical analysis
Dovepress Smith et al
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Content analysis
Inductive content analysis was applied to extracted text and
summarised by a representative phrase. Two of the authors
deductively reviewed and revised the framework until agree-
ment was reached between all authors that it related to the
research question. Six themes emerged that encapsulate the
ﬁndings. These are summarised as follows with illustrative
text for each theme (Table 7) and further details in
Supplementary materials.
Support for long-term follow-up
Long-term follow-up was directly advocated by the
authors in 41 studies, 21 to monitor changes and 20 for
unknown outcomes. The reasons given were evaluation of
the temporal effect on ﬁxation and materials, continued
observation of host response to implanted materials, and to
provide understanding of progressive and potentially
damaging changes, especially in younger patients.
Subgroups requiring follow-up over time
The outcomes of THA in speciﬁc subgroups of patients was
reported in 28 studies—nine monitored changes around the
prosthesis and 19 assessed the patients for unknown out-
comes. The categories included age of patient (10 studies),
weight (three studies), activity levels (three studies), gender
(one study), and a range of diagnoses listed in Table 6.
Some reported survival of the THA in the subgroup; others
reported mid-term results. Many authors advocated longer
follow-up (either explicitly or implicitly) due to concerns
about patterns of failure of the THA in the deﬁned subgroup
of patients and the need for revision.
Effect of materials and techniques on survival of THA
Twenty studies described the effect of a range of materials
and techniques for THA. Materials included titanium,
hydroxyapatite coatings, ceramic-on-ceramic bearings,
metal-on-metal bearings, and polyethylene (the wear
Records identified through database
searching
(N=4,878)
Additional records identified thriough
other sources
(N=65)
Records after duplicates removed
(N=4,137)
Records screened
(N=4,137)
Full-text articles assessed for
eligibility
(N=159)
Studies included in
qualitative synthesis
(N=114)
Full-text articles excluded
(N=45)
In
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y
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Not primary hip arhroplasty 12
Technique based 
No more than 5 years follow-up
Short-term outcomes
Early reports of studies
Patient age less than 20 years
Radiographic or DEXA
Tool development
Secondary data analysis
10
7
1
1
2
2
2
8
Studies included in
quantitative synthesis
(n = 114)
Records excluded
(N=3,978)
Figure 1 Flow diagram showing the results of the literature search.
Abbreviation: DEXA, dual-energy X-ray absorptiometry.
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reduction of highly cross-linked polyethylene was demon-
strated at mid-term). Authors in 13 of the studies claimed
that the results supported continuation of their practice and
in the others, further long-term follow-up was advocated
to assess THA survival; some emphasized the importance
of follow-up into the second and third decades.
Effect of design on survival of THA
Thirteen studies examined the effect of construct design on
THA survival and described outcomes and failure
Table 3 Characteristics of included studies
Data type Range Number
of
studies
Country and num-
ber of studies
Argentina 1, Australia 4,
Canada 7, China 6, England 8,
Finland 1, France 9, Germany
3, Greece 4, Japan 15, Norway
2, Poland 1, Scotland 1, South
Korea 16, Spain 7, Sweden 2,
Switzerland 3, Taiwan 2, The
Netherlands 6, Turkey 1, UK
1, USA 17
114
Contemporary
groups
Yes 44
With baseline equivalence of
groups
20 of 44
No 69
Unclear 1
Inclusion of conse-
cutive patients
Yes 69
No 30
Unclear 15
Setting Single centre 104
Multicentre 10
Clearly stated aim Yes 114
Prospective collec-
tion of data
Prospective 57
Retrospective 57
Endpoints appro-
priate to the aim
of the study
Yes 114
Unbiased assess-
ment of the study
endpoint
Yes 39
No 28
Unclear 47
Loss to follow-up Unknown 13
Zero 19
<5% 8
5 to 10% 21
10.1 to 20% 24
20.1 to 30% 11
(Continued)
0
0
5
10
15
20
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16
M
IN
O
R
S 
sc
or
e
Number of papers
Figure 3 Histogram showing number of studies with MINORS scores for non-
comparative studies (zero=poor, 16=good).
Abbreviation: MINORS, methodological index for nonrandomized studies.
Table 3 (Continued).
Data type Range Number
of
studies
30.1 to 40% 9
40.1 to 50% 4
More than 50% 5
0
0
2
4
M
IN
O
R
S 
sc
or
e
6
1 2 3 4 5 6 7 8 9 10 11 12 13
Number of papers
14 15 16 17 18 19 20 21 22 23 24
Figure 2 Histogram showing number of studies with MINORS scores for com-
parative studies (zero=poor, 24=good).
Abbreviation: MINORS, methodological index for nonrandomized studies.
Dovepress Smith et al
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mechanisms related to ﬁxation, shape of femoral stems and
size of the femoral head.
Indicators for revision
Factors that might predispose to revision THA were
addressed in ﬁve studies; two addressed high polyethylene
wear rates (both predated the introduction of cross-linked
polyethylene), one reported on primary hospital type (no
effect on long-term survival) and two others reported on
the use of radiographic monitoring to identify asympto-
matic loosening.
Elements of the review process
Many studies described the methods of follow-up and,
although most were research studies, some were reporting
results from ongoing surveillance services.19–21
Radiographic assessment was widespread with 101 studies
(89%) reporting radiographic results (Table 4) and most
included a patient-reported outcome score (Table 5). The
use of validated patient-centred outcome scores has
increased over time, with some studies adding a contem-
porary measure to a more traditional one.19,22
Ten deﬁned the processes that should be included in
long-term follow-up of THA, predominantly the inclusion
of radiographic review and the use of outcome scores. Two
studies referred to loosening identiﬁed on X-ray in the
absence of symptoms and highlighted the lack of correla-
tion between the two. Both studies were of a cohort of
cemented THA with polyethylene that predated the use of
cross-linked polyethylene.
There were no studies on the cost-effectiveness of the
review process. One paper presented data on the cost-
effectiveness of the primary hip arthroplasty and the
authors emphasized the importance of patient selection to
maximize value for THA in the longer term.23
Discussion
There were no studies which directly evaluated the clinical or
cost-effectiveness of THA surveillance and so the studies were
analyzed using a combination of descriptive analysis and
qualitative techniques. The summary data demonstrate the
wide range of countries (22 in total) and the signiﬁcant length
of follow-up (up to 27 years) that have contributed to this
review. In addition to the summary data, analysis of authors'
opinions showed that 41 studies speciﬁcally advocated follow-
up and none suggested that it should be abandoned. The
reasons for continued surveillance were because the effect of
time, interaction with the host body and outcome of speciﬁc
techniques are unknown factors, plus the need for evidence of
the outcomes of newer materials and alternative ﬁxation meth-
ods, and most importantly, to provide patient-focussed care. In
addition, the use of follow-up was advocated for subgroups of
patients such as those with dysplasia or avascular necrosis, or
patient characteristics such as the super-obese due to poorer
long-term outcomes which predispose them to revision arthro-
plasty. Other studies emphasized the need for follow-up of
younger or more active patients due to the increased risk of
revision. These comments form a body of expert opinion for
consideration in provision of long-term follow-up services.
As described earlier, long-term follow-up has often
been used to identify asymptomatic failure following
THA. There were 41 studies (Table 4) that speciﬁcally
referred to asymptomatic failure and of these, 29 studies
(70%) were of patients whose primary surgery took place
before the year 2000, which is before the widespread use
of cross-linked polyethylene, the long-term outcomes of
which may change the pattern of presentation. Newer
materials have improved the survival rates and reduced
the need for surveillance in the ﬁrst decade following
THA,4 but surveillance in the second and third decades
was still considered important by many of the authors.
Although new or modiﬁed designs of THA that are intro-
duced in the UK can now be closely monitored,24 and
national joint registries provide data on the longevity of
components, experiences with metal on metal hip arthro-
plasty have highlighted the negative effect of insufﬁcient
surveillance.25 Discoveries in relation to the failure of
THA mean that the interpretation of failure is still evol-
ving, and some long-term follow-up may still be required
to assess the patterns of impending failure and to inform
the future care of patients.1,26,27
Table 4 Summary of extracted data
Data type Value Range
Age of patient (years) 55.7 (mean) 17–98
Number of patients in study 107 (median) 6–18,968
Length of follow-up (years) 11.05 (median) 3.6–26.7
Percentage of cohort revised (all
causes) in each study
5% (median) 0–74%
Radiographic changes results
reported in study
Yes 101
No 13
Asymptomatic loosening
reported in study
Yes 41
No 43
Unclear 30
Smith et al Dovepress
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The methods used in long-term follow-up have not
been precisely deﬁned9 and, although the combination of
outcome scores and radiographic evaluation is common,
their correlation with each other is not guaranteed.28,29 The
implication is that the use of an outcome score without
radiographic evaluation will not be sufﬁcient to monitor
THA.30 Some orthopedic surgeons will consider revision
for radiological loosening in the absence of signiﬁcant
symptoms,31 as “an early revision on adequate bone
stock presents more chance of success and a better func-
tional prognosis for the patient”.32 This illustrates that the
threshold for progression to revision surgery in cases of
aseptic loosening is not a ﬁxed and deﬁnable point, and
that the decision-making process includes both objective
and subjective elements together with patient choice.
We found no evidence of the cost-effectiveness of
THA surveillance. The lack of evidence threatens the
Table 5 Use of outcome scores by country and time
Name of
score
Year of
publication
Number of stu-
dies using score
Country of study Study per-
iod
covered
Scores originally completed by orthopedic surgeon
HHS 1969 73 England, USA, Sweden, France, Korea, China, Ireland, Australia,
Germany, Greece, Japan, Turkey, The Netherlands, Taiwan
1982 to 2011
PMA 1954 15 France, Korea, Greece, The Netherlands, Taiwan, Japan, Poland,
India
1976 to 2010
JOA hip score 1993 5 Japan 1996 to 2005
Scores completed by the patient
HOOS 2003 1 France 2000 to 2008
EQ-5D 1990 3 England, France, Scotland 2000 to 2010
VAS PAIN 1974 2 Argentina, The Netherlands 1985 to 2006
UCLA 1984 10 USA, Switzerland, England, Greece, Korea, Canada, China 1993 to 2011
SF36 1992 7 USA, Japan, England, Canada, The Netherlands 1994 to 2010
OHS 1996 10 England, Finland, Scotland, The Netherlands, UK 1988 to 2010
WOMAC 1988 12 USA, Canada, Spain, Australia, Korea, Greece 1984 to 2006
TEGNER 1985 2 USA 1994 to 2003
SF12 1996 4 Spain, Canada, Australia, Switzerland 1992 to 2011
Unknown scores
Unvalidated
scores
n/a 2 Switzerland, France 1965 to 2008
No score used n/a 11 England, Germany, Japan, France, Sweden, Norway, Greece, USA, Spain 1972 to 2013
Abbreviations: HHS, Harris hips score; PMA, Merle d’Aubigne & Postel; JOA, Japanese Orthopaedic Association; HOOS, hip osteoarthritis outcome score; EQ-5D,
EuroQol health-related questionnaire; VAS, visual analogue scale; UCLA, University of California, Los Angeles activity scale; SF36; Medical Outcomes Study short-form 36
item questionnaire; OHS, Oxford hip score; WOMAC, Western Ontario and McMaster University osteoarthritis index; TEGNER, Tegner activity scale; SF12, Medical
Outcomes Study short-form 12 item questionnaire.
Table 6 Subgroup diagnoses in THA studies
Diagnosis No. of
studies
Diagnosis No. of
studies
Sickle cell
anemia
Acetabular
fracture
Fractured
neck of femur
Hemophilia
Poliomyelitis
1
1
1
1
1
Inﬂammatory arthritis
Developmental dyspla-
sia of the hip
Osteonecrosis of
femoral head
Avascular necrosis of
the femoral head
1
1
2
1
Abbreviation: THA, total hip arthroplasty.
Dovepress Smith et al
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continuation of follow-up services as cost implications are
unknown: can follow-up services reduce costs through
simple, timely revision instead of more complicated,
reconstructive surgery or emergency surgery?33 Although
some studies have evaluated the cost-effectiveness of
THA,34–36 they do not discuss the use of surveillance as
a tool to facilitate “timely” revision. One study which
evaluated the economics of three models of follow-up
recommended less intensive early follow-up.37
Limitations
The strengths and weaknesses of this review are not unique
and are associated with inclusion of observational cohort
studies which are subject to confounding factors and bias,
and impacted by loss to follow-up, particularly when the
study extends over many years.38 The geographic removal
of patients, development of comorbidities or death because
of advanced age, are all known barriers to completion of
longitudinal studies.39 In this review, 63% of studies had loss
to follow-up of ≤20% and the quality was also compromised
by lack of independent assessment of study outcomes; long-
term, single centre studies often have a limited choice of staff
available to obtain study outcomes.40
Future
The growing number of primary THA leads to a growing
number of revision surgeries41 with associated costs. It is
unclear if the use of long-term follow-up can lessen this
burden by identifying patients in time for a relatively simple
revision or reducing the number of those requiring emer-
gency surgery for periprosthetic fracture. Currently, the pro-
vision of THA surveillance is sporadic and the cost of
delivering it proves prohibitive for many hospitals, leading
to consideration of alternative models of follow-up.42,43 A
research programme in the UK is currently exploring the
implications for disinvestment and the outcomes will be
Table 7 Themes and illustrative quotes from content analysis
Theme Representative quote
Support for long-term follow-up “The fact that expansile osteolysis does not always lead to symptomatic loosening points to the necessity
of close radiographic monitoring of the patients with total hip arthroplasty, especially in those with
uncemented acetabular components.” Hartoﬁlakidis et al45
“For interpretation of their clinical relevance, they need correlation with long-term clinical results,
radiographic scores or implant survival. Consequent follow-up is obligatory and will be performed to
clarify the link between early predictions and real long-term outcome.” Broeke et al46
Subgroups requiring follow-up over
time
“In this randomized controlled design, we found age and gender to be important prognosticators for THA
failure. … The requirements of implants to withstand the activity level of patients thus are gender-speciﬁc
with the most strenuous requirements being for male patients.” Corten et al47
“Further studies with longer follow-up are needed to better evaluate the outcomes of these patients…
super-obese patients achieved… lower clinical outcome scores, a higher revision rate, and higher
complications …compared with the matched group of non-obese patients at a mean follow-up of six
years.” Issa et al48
Effect of materials and techniques on
survival of THA
“the long-term … results of ABG-1TM implants used in primary implantation for THAs underscores the
frequency of retroacetabular osteolysis … encourages us to propose regular monitoring of these patients
after 10 years of implantation as well as early preventive acetabular revision when progressive osteolysis
occurs.” Bidar et al31
Effect of design on survival of THA “Charnley cemented and Furlong HAC-coated uncemented hip prostheses had similar survival rates at 12
to 16 years… commonest cause of revision in the Furlong group was severe polyethylene wear, and all
revisions in the Charnley group were due to aseptic loosening of the stem.” Chandran et al49
Indicators for revision “We consider radiological loosening as an indication for surgical revision, as osteolysis progresses at least
linearly, so an early revision on adequate bone stock presents more chances of success and a better
functional prognosis for the patient.” Boyer et al32
Elements of the review process “The other conclusion that can be drawn from our study is that radiological evidence of loosening does
not necessarily have to correlate with clinical symptoms in long-term follow-ups.” Shaju et al29
Abbreviation: THA, total hip arthroplasty.
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relevant for patients, health professionals and commissioners
when considering future services.44 With the current empha-
sis on patient-centred care and long-term conditions, there
may be beneﬁt in offering selected subgroups of patients a
choice for follow-up. The model of delivery of such a service
should be time and cost-efﬁcient, and responsive to change as
new evidence emerges from national joint registries.
Conclusion
We systematically reviewed the literature for evidence of
the clinical effectiveness of long-term follow-up of hip
arthroplasty. We were unable to identify speciﬁc quantita-
tive evidence but the evaluation of authors’ comments
from a wide range of countries offers expert insight into
the use of follow-up in the continuing provision of long-
term, patient-centred care following total hip replacement.
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